|Role this area should play in the mHealth space
mHealth solutions can play important roles in the management of infectious diseases, especially long-term treatments such as for tuberculosis. However, there are also innovations in diagnostics using classical mobile phone hardware components like the camera and microphone. The contributions of mHealth have expanded and become more widely recognised during the COVID-19 pandemic.
|Current challenges and limitations
|What benefit could this bring to adopters of this innovation?
|This area would be of greatest value to persons responsible for managing infectious disease outbreaks or public health programmes, including infection control programs, to help them to understand the possible contributions that mHealth tools could make.
|How does it contribute to major EU policy priorities? (e.g. EHDS, COVID-19, DTHC etc.)
|This section directly supports Member States and regional health systems with insights into innovations that can support them during the COVD-19 pandemic.
No post found
|What is on the horizon?
|Some of the greatest advances that are forthcoming that will revolutionise the role of mobile health solutions in infection management include more accurate location and proximity alerts, lab-on-a-chip developments to enable early and remote diagnosis, which will limit disease spread and enable more rapid treatments, and the use of AI for remote diagnosis and the early detection of deterioration.